The formation of the vertebrate brain requires the generation, migration, differentiation and survival of neurons. Genetic mutations that perturb these critical cellular events can result in malformations of the telencephalon, providing a molecular window into brain development. Here we report the identification of an N-ethyl-N-nitrosourea-induced mouse mutant characterized by a fractured hippocampal pyramidal cell layer, attributable to defects in neuronal migration. We show that this is caused by a hypomorphic mutation in Vps15 that perturbs endosomal-lysosomal trafficking and autophagy, resulting in an upregulation of Nischarin, which inhibits Pak1 signaling. The complete ablation of Vps15 results in the accumulation of autophagic substrates, the induction of apoptosis and severe cortical atrophy. Finally, we report that mutations in VPS15 are associated with cortical atrophy and epilepsy in humans. These data highlight the importance of the Vps15-Vps34 complex and the Nischarin-Pak1 signaling hub in the development of the telencephalon.
1
. In the case of the cortex and hippocampus, neurogenesis occurs in the proliferative ventricular zones where radial glia and intermediate progenitors undergo extensive neurogenic divisions 2 . The resultant postmitotic neurons then begin a cellular journey, undertaking a series of genetically programmed morphological transitions before propelling themselves along the radial glia scaffold forming a laminar structure 3 . This migration requires the generation of polarity, extension of a leading process, translocation of the nucleus and retraction of the trailing process. Having reached their final destination, neurons mature through a process of differentiation that involves axon extension and the formation of dendritic processes.
Insight into the molecular mechanisms that mediate these critical cellular processes have been informed by the study of spontaneous and N-ethyl-N-nitrosourea (ENU)-induced mouse mutants 4 . For instance, the reeler mouse revealed the importance of the extracellular signaling protein Reelin 5 , the scrambler mutant implicated the tyrosine phosphatase Dab1 6 and the Tuba1a mouse mutant has underlined the role of the microtubule cytoskeleton 7 . The study of engineered mouse mutants has also been pivotal, highlighting the role of nonreceptor protein kinases such as JNK and Cdk5 8 . Cdk5 sits at the intersection of a signaling pathway, phosphorylating molecules such as Dab1, Dcx, Map1b and Pak1 9 . Pak1, which is an effector of Rac1 and Cdc42, has been implicated in the regulation of actin and microtubule dynamics. While these functional studies have advanced our understanding of the molecular mechanisms that mediate neuronal migration, it is nonetheless apparent that the picture is far from complete. In this study we established a genetic screen in mice to identify new genes required for telencephalic development, with a focus on neuronal migration. We report that mutations in Vps15 impair the migration and survival of neurons in mice depending on the protein dosage and that mutations in the human homolog are associated with neurodevelopmental disease.
Results
ENU screen, genetic mapping and rescue. We performed a recessive ENU screen, undertaking a quantitative and qualitative analysis of structural brain phenotypes in the adult mouse brain (Fig. 1a) . This screen employed Nissl staining and assessed such attributes as ventricular volume, cortical thickness, the thickness of hippocampal layers, corpus callosal volume and the presence of ectopic cells ( Supplementary Fig. 1a ). We screened a total of 38 pedigrees, each with at least 12 animals per line. Based on the observed rate of ENUinduced mutations, this represents approximately 2.7% coverage of the coding genes in the mouse genome 10 . We identified six pedigrees with a variety of neuroanatomical abnormalities, one of which presented with striking pyramidal cell ectopia in the hippocampus, reminiscent of Tuba1a, Dcx and Lis1 mutant mice (Fig. 1d ,e,g,h) 7, 11, 12 . To identify the causative mutation in this recessive line, nicknamed Marble, we adopted a traditional positional cloning strategy employing microsatellite markers. This approach narrowed the genomic interval to a 28.6-Mb region on distal chromosome 9 that contains 439 genes ( Supplementary Fig. 1b ). Whole-exome sequencing failed to identify any coding variants within this region, but revealed the presence of a T-to-A substitution in the intron upstream of exon 4 of Vps15 (GRCm38p4, chr9: 105,650,312; Fig. 1b ). This mutation was not found in either of the strains used for mapping (C3H/HeH and C57/BL6J mice), nor is it reported to be a naturally occurring polymorphism in wild-type or inbred mice. The T-to-A mutation creates a novel splice acceptor site, which is predicted to introduce a premature stop codon resulting in a truncated protein of 289 amino acids (Fig. 1c) . We extracted mRNA from the developing brain (at embryonic day (E) 14.5) of homozygous mutants (Mbe/Mbe) and confirmed the introduction of this stop codon into the transcript ( Supplementary Fig. 1c ). To formally test whether the mutation in Vps15 is responsible for the fractured pyramidal cell layer in the Marble line, we performed a rescue experiment by creating a bacterial artificial chromosome (BAC) transgenic mouse that has additional copies of Vps15. We selected a BAC (RP24-281C16) that contains the complete sequence of Vps15 and the partial sequence of the neighboring gene Col6a6. Following pronuclear injections and confirmation of germline transmission, we analyzed our BAC transgenic animals, confirming that the presence of additional copies of Vps15 does not result in a neurological phenotype ( Supplementary  Fig. 1d-m) . We then crossed our BAC transgenic mice into the Marble line. We found that homozygous Mbe/Mbe mutants with the BAC transgene were indistinguishable from wild-type controls ( Fig. 1d-i) . Collectively, these data show that Vps15 is necessary for neuronal migration in the murine hippocampus.
Mutations in
The Mbe/Mbe mutation impairs the function of the Vps15-Vps34 complex. Vps15 is known to form a complex with Vps34 and Beclin1, catalyzing the formation of the phospholipid PI(3)P, which is important for the maturation of endosomes as well as the formation of autophagosomes 13, 14 . Its essential role in vesicular processes is reflected by its ubiquitous expression pattern, which we confirmed by quantitative PCR (qPCR) ( Supplementary Fig. 2a-c) . To assess whether the Marble mutation perturbs the Vps15-Vps34-Beclin1 complex we extracted protein lysates from the developing mouse forebrain (E14.5) and mouse embryonic fibroblasts (MEFs) and performed western blot analysis. This revealed a large reduction in the total protein levels of full-length Vps15 and its binding partners Vps34 and Beclin1 in Mbe/Mbe mutants in the developing forebrain and in MEFs (Fig. 2a,b and Supplementary  Fig. 2d ,e). We were not able to detect a truncated form of the Vps15 protein in Mbe/Mbe MEF lysates using an N-terminal antibody ( Supplementary Fig. 2g,h ). An assessment of Vps15 transcript levels in the developing forebrain (E14.5) of Mbe/Mbe mutants revealed a reduction in Vps15 mRNA consistent with nonsense mediated degradation; however, this reduction was not statistically significant (P = 0.2; Supplementary Fig. 2f and Supplementary Tables 1  and 2 ). Transcript levels of Vps34 and Beclin1 were similar in Mbe/ Mbe mutants and wild-type controls, indicating that the downregulation of these proteins was a consequence of post-transcriptional dysfunction. To assess the effect of the Mbe/Mbe mutation on endosomal trafficking, we performed an epidermal growth factor . Treatment of MEFs with epidermal growth factor (EGF) results in a near complete degradation of the EGF-EGFR complex as internalized endosomes fuse with lysosomes. We pulsed MEFs with EGF and monitored the levels of EGFR over 4 h with normalization to Gapdh. We observed a rapid decrease in the levels of EGFR in wild-type cells that was absent in Mbe/Mbe mutants, most notably at 60 min (Fig. 2c,d ). Consistent with this result, we observed an increased half-life of the PDGF receptor in Mbe/Mbe mutant MEFs following stimulation with the ligand PDGF-BB 16 ( Supplementary Fig. 2i,j ). An assessment of lysosomal function using LysoTracker revealed no difference between genotypes ( Supplementary Fig. 2k,l) . Together, these data indicate that the mutation in Vps15 compromises endosome to lysosome trafficking but not lysosomal function. 762, P = 0.01). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant. All immunoblots shown are cropped; for full-length blots see Supplementary Fig. 11 . Error bars show mean ± s.e.m.
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Next, we assessed the effect of the Mbe/Mbe mutation on autophagy, by undertaking LC3 western blot analysis of protein lysates from MEFs ( Fig. 2e-h ). Autophagosomes are associated with the lipidation of the cytosolic form of LC3 (LC3-I), forming LC3-II. Following the fusion of autophagosomes with lysosomes, LC3-II is degraded by lysosomal proteases 17 . Consistent with a reduction in the number of autophagosomes, we observed a decreased ratio of LC3-II to LC3-I in Mbe/Mbe mutants (Fig. 2e,f) . We assessed autophagy flux by incubating Mbe/Mbe MEFs with bafilomycin A1, which inhibits the fusion of autophagosomes with lysosomes. Analysis of LC3-II levels at 2 and 4 h relative to Gapdh levels revealed no differences in the flux of autophagosomes in Mbe/Mbe MEFs. These data indicate that there is a reduction in the initial pool of autophagosomes in Mbe/ Mbe animals. Previous studies have shown that defects in autophagy can result in the accumulation of ubiquitinated substrates 18 . To ascertain whether this occurs in Mbe/Mbe mutants, we performed western blot analysis of MEF protein lysates with a ubiquitin antibody. This revealed a mild, but significant, upregulation of ubiquitinated proteins in Mbe/Mbe MEFs (n = 3, P = 0.01; Fig. 2i,j) . These data show that the Mbe/Mbe mutation compromises the function of the Vps15-Vps34 complex, impairing endosomal-to-lysosomal trafficking, accompanied by a reduction in the pool of autophagosomes.
Hippocampal proteomics reveals that Nischarin-Pak1 signaling is perturbed in Mbe/Mbe animals. To gain further insight into the molecular mechanisms, we assessed the impact of the Vps15 mutation on the global proteome of the developing hippocampus in Mbe/ Mbe mutants. We chose to analyze mice at postnatal day (P) 0, as pyramidal cell neurogenesis peaks at E14 to E16 and the subsequent migration takes 5-7 d. Extracted protein samples from P0 hippocampi from wild-type and mutant animals (n = 3 replicates per genotype) were digested with trypsin, labeled with tandem mass tags and subjected to mass spectrometry (Fig. 3a) . We generated a total of 1.1 million spectra, enabling the identification of 51,506 unique peptides. We observed at least 49,000 peptides in each sample, which were then mapped to 7,566 Swiss-Prot accessions. We employed this dataset as a discovery tool, applying a modified t test that incorporates a Bayesian approach 19 . We set a threshold of P < 0.01, resulting in the identification of 91 proteins that were more abundant and 96 that were less abundant in the Mbe/Mbe hippocampus (Supplementary Table 3 ). Consistent with results from our western blot experiments, we observed that Beclin1, Vps15 and Vps34 were all less abundant (Fig. 3b) . We employed the Ingenuity software platform (Qiagen) to identify those proteins associated with cell movement (n = 18 proteins). We then manually annotated each of these proteins, drawing on the published literature, and identified six dysregulated proteins known to be involved in neuronal migration (RhoA, Jam3, Nischarin, Slit2, Fgfr3 and Ephb3), one of which (Nischarin) also harbored a phosphoinositol binding domain (Fig. 3c) . We confirmed that Nischarin is more abundant in the Mbe/Mbe hippocampus, cortex and E14.5 forebrain by western blot analysis (Fig. 3d,e) . In contrast, the levels of Nischarin mRNA were similar when comparing Mbe/ Mbe mutants and controls, indicative of post-translational dysregulation (Fig. 3f) . Nischarin is broadly expressed at low levels in adult organs, but is enriched in the developing mouse brain ( Supplementary  Fig. 3a,b) . It is a cytoplasmic protein with a PX domain that binds PI(3)P, and it is targeted to endosomes 20 . It is known to bind integrins and inhibit cellular migration through a Rac1-Pak1 signaling pathway 21 . We asked whether the upregulation of Nischarin in the Marble mouse perturbs Pak1 activation by performing western blot analysis for the phosphorylated active (T422) form of Pak1 on P0 hippocampal lysates. This experiment revealed a significant reduction in the amount of activated Pak1 in Mbe/Mbe mutants in comparison to controls (n = 3, P = 0.01; Fig. 3g,h ). Taken together, these data show that the Mbe/Mbe mutation alters protein homeostasis within the developing hippocampus, perturbing Nischarin-Pak1 signaling.
Mbe/Mbe mutants have a severe defect in hippocampal neuronal migration and working memory. Next, we undertook a detailed examination of the neuroanatomical features of the Marble line, focusing on the hippocampus (Fig. 4a-i) . Staining with the postmitotic neuronal marker NeuN and the calcium binding protein calbindin showed that the ectopic cells displaced in the stratum oriens layer of the hippocampus are excitatory pyramidal neurons ( Fig. 4d-i ) 22 . These ectopic clusters of neurons were most prominent in the CA1 subfield (Fig. 4a-c) . Notably, immunostaining in Mbe/Mbe mutants revealed an enrichment of Nischarin in ectopic pyramidal cells compared with those cells that were correctly positioned ( Supplementary Fig. 3c-g ). Staining with calretinin and parvalbumin showed that the distribution of interneurons within the oriens layer and pyramidal cell layer is not altered in Mbe/Mbe animals ( Supplementary Fig. 4a-n) . Golgi staining revealed no difference in spine density when comparing control (+ /+ ) and Mbe/ Mbe pyramidal neurons ( Supplementary Fig. 4o,p) . In contrast, a Sholl analysis highlighted a significant decrease in dendritic complexity in ectopic CA1 pyramidal cell neurons in Mbe/Mbe mutants that was not evident in correctly positioned neurons in Mbe/Mbe mutants or wild-type littermates (n = 3 animals per genotype, P < 0.0001; Supplementary Fig. 4q ,r). Staining of the dentate gyrus with sera against GFAP (which labels glial-like progenitors), Tbr2 (which labels intermediate progenitors), Dcx (which labels newly born neurons) and Prox1 (which labels granule cells) revealed that the organization of the subgranular zone and granule cell layer is not affected in Mbe/Mbe mutants (n = 3; Supplementary Fig. 5a -x). To investigate the origin of the fractured pyramidal cell layer in Mbe/Mbe mutants, we performed birthdate labeling, injecting BrdU at E14.5, a peak time for hippocampal neurogenesis, and killed the mice and collected their brains at P11 (n = 3). Blind quantitation revealed a significantly higher percentage of BrdU + cells in the stratum oriens in mutant animals (15.2% ± 1.2%) in comparison to littermate controls (10.4% ± 0.1%; n = 3, P = 0.0002). This was accompanied by a concomitant decrease in BrdU + cells in the pyramidal cell layer in Mbe/Mbe animals (n = 3; + /+: 59.6% ± 0.5%, Mbe/Mbe: 54.5% ± 1%, P < 0.0001; Fig. 4j ,k). To assess whether ectopic neurons in the pyramidal cell layer are generated during a broader time window, we performed additional BrdU labeling at E12.5 and E16.5, quantifying the percentage of ectopic BrdU + NeuN + cells (n = 3). This experiment showed that the neurons that form the ectopic layer are born at E12.5, E14.5 and E16.5 ( Fig. 4l-w) .
Next, we asked whether perturbation of Vps15 in neurons is sufficient to cause a fractured pyramidal cell layer in the hippocampus by exploiting a Vps15-conditional knockout mouse 23 . As adult homozygous knockout (loxP-flanked; hereafter fl) animals are not viable, we intercrossed the conditional-knockout line with Mbe/ Mbe mutants, generating compound heterozygotes (fl/Mbe). In the absence of a Cre-recombinase, we observed normal lamination in the hippocampus (Fig. 4x,aa) . We then performed genetic crosses, introducing either Emx1-Cre (which is expressed in both neurons and radial glia in the forebrain from E10.5) 24 or Nex-Cre (which is only expressed in postmitotic neurons in the cortex and hippocampus from E11.5) 25 . Both the fl/Mbe Nex-Cre and fl/Mbe Emx1-Cre lines recapitulated the fractured pyramidal cell layer we observed in Mbe/Mbe mutants, with an increase in the number of ectopic pyramidal cells (Fig. 4y,ab) . The numbers of ectopic cells in the oriens layer were similar in fl/Mbe Emx1-Cre (31% ± 4.5%, n = 3) and fl/Mbe Nex-Cre (38% ± 3%, n = 2) animals ( Fig. 4z,ac) . These data indicate that the fractured pyramidal cell layer we observed in the Mbe/Mbe hippocampus is attributable to Vps15 perturbation in neurons and not to glial dysfunction.
Given the defects in hippocampal lamination in the Mbe/Mbe mice we assessed their performance on a memory task that is hippocampal dependent. Employing rewarded alternation in the T-maze, we found that Mbe/Mbe mutants alternated just above Articles NaTure NeuroscieNce chance (54% ± 4%), in contrast to heterozygotes (71% ± 3%) and + /+ (70% ± 3%) littermates ( Supplementary Fig. 5y,z) . Similarly, they exhibit no defects in motor coordination when assessed with the rotarod (n = 19; Mbe/Mbe vs. + /+ , P = 0.85; Fig. 4af ). Taken together, these data show that the primary behavioral deficit in Mbe/Mbe mutants is working spatial memory, which is associated with a fractured pyramidal cell layer in the hippocampus.
Mbe/Mbe mutants have a mild defect in cortical neuronal migration.
We investigated whether the laminar architecture of the cortex is also affected in Mbe/Mbe mutants by staining with sera against NeuN, Cux1 (a layer II/III and IV marker), Er81 (a layer V marker) and Foxp2 (a layer VI marker; n = 3; Fig. 5a -l). Using these antibodies, we were not able to detect any differences when comparing wild-type controls and Mbe/Mbe mutants, indicating that the structure of the cortex is intact in mutant animals. Next, we assessed neuronal migration in the cortex by birthdate-labeling experiments at E12.5, E14.5 and E16.5, after which mice were killed for analysis (blind quantitation) at P0. We divided the cortex into ten equal bins and counted the number of BrdU + cells in each bin. We observed a mild migratory defect in Mbe/Mbe animals that was most noticeable following injection at E16.5. At this timepoint there was a significant accumulation of BrdU + neurons in bins 9 and 10, with a concomitant decrease in bin 8 in Mbe/Mbe mutants (n = 3, + /+ vs. Mbe/Mbe; bin 8: P = 0.01; bin 9: P = 0.02; bin 10: P = 0.002). Hippocampi from Mbe/Mbe mutants and wild-type controls at P0 (n = 3 biological replicates per genotype, each consisting of pooled hippocampi from 2 animals) were lysed, and proteins extracted and subjected to tryptic digest before tandem mass tag (TMT) labeling. Following separation of protein fragments by liquid chromatography, samples were analyzed by mass spectrometry. b, Volcano plot showing peptides upregulated and downregulated in the Mbe/Mbe hippocampus with -log 10 (P) values shown on the y axis, following the application of a modified t test with Bayesian parameters. c, Pyramid showing how mass spectrometry data were analyzed. d,e, Western blot analysis and quantification confirm that Nischarin protein levels are increased in the Mbe/Mbe developing forebrain (E14.5; n = 3 animals per genotype; one-tailed unpaired t test; t 4 = 3.667, P = 0.01), P0 cortex (n = 3 animals per genotype; one-tailed unpaired t test; t 4 = 19.19, P < 0.0001) and P0 hippocampus (n = 6 animals per genotype; one-tailed unpaired t test; t 10 = 2.584, P = 0.01). This experiment was performed twice with similar results. f, Quantification of mRNA expression of Nischarin in the E14.5 forebrain reveals no differences between genotypes (n = 3 animals per genotype; Mann-Whitney test, two tailed; P = 0.4). g, Western blot analysis of activated Pak1 (phosphorylated at T422) shows decreased Pak1 activation in the Mbe/Mbe P0 hippocampus. This experiment was performed twice with similar results. h, Quantification of Pak1 western blot reveals that the difference between genotypes is significant (n = 3 animals per genotype; one-tailed unpaired t test; t 4 = 3.597, P = 0.01). *P < 0.05; ****P < 0.0001; ns, not significant. All immunoblots shown are cropped; see Supplementary 
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Mbe/Mbe, P = 0.13) or 4 months (n = 3; + /+ vs. Mbe/Mbe, P = 0.93; Fig. 5q-w) . Analysis of the laminar structure of the cerebellum, employing markers such as Foxp2 and calbindin, revealed no differences between genotypes ( Supplementary Fig. 6i-q) .
Acute depletion of Vps15 causes neuronal migration defects in the murine cortex. As the Mbe/Mbe mutation results in some functional protein, we explored the effect of acute depletion of Vps15 in the developing cortex. We performed in utero electroporation on Vps15-knockout animals at E14.5, delivering a Cre recombinase alongside a GFP-expressing vector. Animals were killed for analysis at E17.5, and the distribution of GFP + cells was blindly quantitated. We found that acute depletion of Vps15 results in a severe migration defect, with a notable reduction of GFP + cells in the outer cortical plate (oCP; n = 6, P < 0.0001; Fig. 5x-z) . Given that Nischarin is found at higher levels in Mbe/Mbe mutants, we then asked whether Nischarin knockdown might rescue the aforementioned migration defect. First, we confirmed that knockdown of Nischarin, by itself, does not influence neuronal migration, by delivering short hairpin microRNAs (shmiRNAs) validated in Neuro2A cells to the developing cortex ( Supplementary Fig. 7a-e) . Next, we delivered a Cre recombinase to Vps15-conditional knockout animals at E14.5 with shmiRNAs targeted to Nischarin or, alternatively, a scrambled control. Blind quantitation showed that Nischarin knockdown partially rescued the cortical migration defect that results from acute Vps15 depletion (n = 4, P = 0.003, oCP; Fig. 5aa-ac) . Given the decreased phosphorylation (T422) of the downstream Nischarin effector Pak1 in Mbe/Mbe mutants, we then asked whether the effect of acute Vps15 ablation could be alleviated by expression of a Pak1 phosphomimetic. While overexpression of T422E Pak1 itself does not significantly influence the distribution of neurons (n = 4 animals per condition, interaction P = 0.7074; Supplementary Fig. 7f-h ), when delivered with a Cre recombinase on the Vps15-knockout background, it enhanced neuronal migration (n = 6, P = 0.003, oCP; Fig. 5ad-af) . We further predicted that overexpression of Nischarin would cause a severe defect in migration in wild-type animals. To test this, we performed in utero electroporation of wild-type C57/Bl6J mice, which were killed for analysis at E17.5. Blind quantitation revealed an increase in the number of GFP + cells in the subventricular and ventricular zones in animals overexpressing Nischarin, with a concomitant reduction in oCP (n = 4, P = 0.005; Fig. 5ag-ai and Supplementary Fig. 7i-n) . Taken together, these experiments support the hypothesis that neuronal migration defects caused by Vps15 depletion are associated with perturbation of a Nischarin-Pak1 signaling pathway.
Complete ablation of Vps15 causes severe cortical atrophy. Next, we explored the impact of a complete ablation of Vps15 in the telencephalon, using a Vps15-conditional knockout animal crossed 
NaTure NeuroscieNce to the Emx1-Cre driver line 23 . We did not observe a phenotype in heterozygous animals (+/fl Emx1-Cre) but noted a reduction in cortical thickness in homozygotes (fl/fl Emx1-Cre) at P0 that was more severe at P11 (Fig. 6a-h ). At both timepoints the hippocampus was barely discernible, with no structured pyramidal cell layer or dentate gyrus. This degeneration was accompanied by a large increase in caspase-3 + apoptotic cells in fl/fl Emx1-Cre animals at P0 (Fig. 6i-k) . This phenotype was also evident at E14.5, where we again observed a reduction in cortical thickness, with extensive apoptosis in proliferative and postmitotic regions ( Supplementary  Fig. 8a-g ). At E14.5 we observed a reduction in the thickness of Sox2 + and Tbr2 + progenitors, a decrease in the mitotic output as assessed by pH3 staining and a disorganized radial glial scaffold in fl/fl Emx1-Cre animals ( Supplementary Fig. 8h-s) . Next, we undertook histological analysis of P0 cortical sections stained with sera against LC3 and p62, which serves a cargo receptor for the autophagic degradation of ubiquitinated substrates 26 . We observed a large increase in the number of cells with p62 + (Fig. 6o-q ) and LC3 + ( Fig. 6l-n) puncta. Taken together, these data show that complete ablation of Vps15 results in severe, progressive degeneration of the hippocampus and cortex that is associated with caspase-induced apoptosis and the accumulation of LC3 + and p62 + substrates.
Mutations in VPS15 are associated with neurodevelopmental disease in humans.
Given that the Mbe/Mbe mice present with defects in neuronal migration and that complete ablation of Vps15 The father and mother are heterozygous for the variant, whereas the proband (filled box) is homozygous for the L1224R mutation. Unaffected siblings were either heterozygous or wild-type. b,c, MRI images of the affected patient (at age 16) who presents with bilateral cortical and optic nerve atrophy, regions of cortical dysplasia (arrowheads), ataxia, intellectual impairment and epilepsy. d, Structural model of the VPS15-VPS34-BECLIN1 complex, with VPS15 shown in pink. The L1224R mutation lies in the WD40 domain in the fourth beta strand and is part of a hydrophobic core (red dot). e, Western blot analysis of VPS15, VPS34, BECLIN1 and P62 in protein lysates from dermal fibroblasts obtained from the father (F), mother (M) and proband (L1224R). f-i, Normalization with GAPDH reveals a highly significant reductions in VPS15, VPS34 and BECLIN1 in the affected proband and mild reductions in VPS15 and VPS34 in the father (n = 3 separate flasks per individual, one-way ANOVA with Tukey's multiple comparison; VPS15: father vs. mother, P = 0.036; father vs. proband, P = 0.0007; mother vs. proband, P < 0.0001; VPS34: father vs. mother, P = 0.01; father vs. proband, P = 0.009; mother vs. proband, P = 0.0002; BECLIN1: father vs. proband, P = 0.004; mother vs. proband, P = 0.0052; P62: father vs. proband, P = 0.02; mother vs. proband, P = 0.006). These experiments were performed twice with similar results. j, Western blot analysis of lentiviral rescue experiment. L1224R fibroblasts were infected with a lentivirus expressing either mCherry (control), or mCherry + wild-type VPS15 (rescue). k-m, This resulted in significant increases in VPS15, VPS34 and BECLIN1 in the rescue cells (n = 3 separate flasks per individual, one-tailed unpaired t test; VPS15: P = 0.002; VPS34: P = 0.03; BECLIN1: P = 0.001). These experiments were performed twice with similar results. n, Ectopic expression of VPS15 in L1224R cells resulted in a significant reduction in P62 (n = 3 separate flasks per individual, one-tailed unpaired t test, P = 0.015). All immunoblots shown are cropped; see Supplementary Fig. 11 for full-length blots). Error bars show mean ± s.e.m. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
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NaTure NeuroscieNce results in severe cortical atrophy, we explored whether mutations in the human homolog would result in structural brain phenotypes. We networked with clinical geneticists through interfaces such as Genematcher 27 . This resulted in the identification of a family with non-consanguineous parents in which one of four children presented with severe cortical and optic nerve atrophy, localized cortical dysplasia, intellectual impairment, spasticity, ataxia, psychomotor delay, muscle wasting, pseudobulbar palsy, a mild hearing deficit and late-onset epilepsy (Fig. 7a-c) . Whole-exome sequencing (WES) of all family members identified a single homozygous coding variant in the affected patient that was not reported in online genome databases (for example, ExAC genome browser). We did not identify any other unreported de novo or inherited variants in the affected patient. This variant, an A-to-C mutation in VPS15 (GRCh38.p5; chr3: 130,681,528), alters a highly conserved leucine residue to arginine (L1224R) (Supplementary Fig. 9a,b) . One unaffected sibling and both unaffected parents are heterozygous for this variant. We mapped the position of the mutation onto the structure of the yeast Vps15-Vps34-Beclin1 complex. L1224 lies within the WD40 domain of Vps15 on the fourth beta strand, a blade that is important for folding and stability 28 ( Fig. 7d) . We hypothesized that the L1224R mutation might compromise the stability of this protein complex. To test this, we obtained dermal fibroblasts from the affected individual and his parents. Western blot analysis revealed a large reduction in the amount of VPS15 protein in the proband in comparison to parental fibroblasts (n = 3 replicates, proband vs. mother: P < 0.0001; proband vs. father: P = 0.0007; Fig. 7e,f) . We also observed a concomitant decrease in the levels of VPS34 and BECLIN1 in fibroblasts of the affected patient (n = 3 replicates, VPS34: proband vs. mother, P = 0.0002; proband vs. father, P = 0.009; BECLIN1: proband vs. mother, P = 0.002; proband vs. father, P = 0.004; Fig. 7e,g,h) . In general, we observed reduced levels of the VPS15-BECLIN1-VPS34 complex in the father in comparison to the mother. We did not observe any significant differences in mRNA levels for VPS15, VPS34 and BECLIN1 when comparing patient and parent cell lines, indicating that the reduction in protein levels is due to post-transcriptional dysregulation ( Supplementary Fig. 9c ). An assessment of the number of autophagosomes and autophagy flux by analysis of LC3-I and LC3-II levels revealed a mild impairment in the patient when compared to his parents, but this difference was not statistically significant ( Supplementary Fig. 9d-g ). In contrast, we did observe a significant increase in the levels of the autophagy cargo receptor P62 (n = 3, proband vs. mother: P = 0.006; proband vs. father: P = 0.02; Fig. 7e,i) and a reduction in LysoTracker staining in the cells of the proband when compared to the father (n = 3, proband vs. father: P = 0.046; Supplementary Fig. 9h,i) .
We asked whether we could rescue the accumulation of P62 + autophagic substrates in the L1224R patient cells by ectopically expressing wild-type VPS15. To do so, we generated a lentivirus that expresses VPS15 and mCherry. Delivery of this virus to patient cells resulted in upregulation of the VPS15 protein and stabilization of BECLIN1 and VPS34 levels ( Fig. 7j-m) . Moreover, in comparison to infected control cells, we observed a significant decrease in P62 levels upon ectopic expression of VPS15 (n = 3, P = 0.015; Fig. 7j,n) . Taken together, these data show that the L1224R mutation compromises the function of the VPS15-BECLIN1-VPS34 complex, leads to an accumulation of autophagic substrates and indicates that mutations in VPS15 are associated with human neurodevelopmental disease.
Discussion
The role of Vps15 in neuronal migration. Here we report the establishment of a forward genetics screen for mice with structural brain phenotypes. This has resulted in the identification of the Marble mouse, which presents with a fractured pyramidal cell layer in the hippocampus, attributable to an impairment in neuronal migration and a hypomorphic mutation in Vps15. How do mutations in Vps15 cause defects in neuronal migration? We have shown that there is a large increase in Nischarin in the developing telencephalon in Mbe/Mbe mutants, accompanied by reduction in activated Pak1. This result is consistent with previous studies showing that Nischarin binds to and inhibits the kinase activity of Pak1, exerting an inhibitory impact on cell migration 21 . This is further reinforced by our in utero electroporations, which showed that acute ablation of Vps15 in the cortex results in a migration defect that can be rescued, in part, by reducing the levels of Nischarin or by overexpression of a Pak1 phosphomimetic. Pak1 is known to play a critical role in cytoskeletal organization, by influencing microtubule dynamics through the phosphorylation of tubulin cofactor B 29 . Pak1 has also been reported to influence the actin cytoskeleton by activating LIM kinase (LIMK1), which regulates cofilin phosphorylation 30 . There is further evidence that the amino terminus of Nischarin binds directly to the PDZ domains of LIMK1, exerting an inhibitory effect 31 . Cofilin phosphorylation has been shown to stabilize the actin cytoskeleton in the leading process of migrating neurons, promoting somal translocation 32 . The reduced levels of activated Pak1 in Mbe/Mbe mutants and the abundance of Nischarin might result in decreased cofilin phosphorylation, destabilizing the leading process. As Nischarin is known to bind integrins, it is also conceivable that the distribution of cell surface receptors may be altered in Mbe/ Mbe mutants. Anton and colleagues have shown that perturbation of integrin signaling in α 3β 10-deficient neurons results in a defect in neuronal migration that is associated with altered actin dynamics in the leading and trailing processes 33 . In light of this fact, and as Nischarin and Pak1 have multiple effectors, we propose that the neuronal migration defect in Mbe/Mbe mutants involves multiple pathways that converge on the microtubule and actin cytoskeleton ( Supplementary Fig. 10 ). We emphasize that we cannot exclude the possibility that other proteins misregulated in the Marble mouse (for example, Fgfr3 or Slit2) also contribute to the phenotype; however, it is apparent that overexpression of Nischarin alone is sufficient to result in a neuronal migration phenotype.
Phospholipids and neurodevelopmental disease. Evidence that abnormalities in the processing of various phospholipids cause neurodevelopmental syndromes 34 is accumulating. Genetic studies in humans have shown that mutations in PIK3R2 and PIK3CA cause a spectrum of phenotypes, including megalencephaly, polymicrogyria and focal cortical dysplasia, the last of which in some instances is accompanied by hydrocephalus and polydactyly 35, 36 . Together, PIK3R2 and PIK3CA are responsible for phosphorylating phosphatidylinositol 4,5-bisphosphate, generating phosphatidylinositol 3,4,5-trisphosphate (PIP3), which regulates a wide range of cellular processes. More recently, mutations in SNX14, a protein that is associated with late endosomes and lysosomes and that binds to phosphatidylinositol (3,5)-bisphosphate, was shown to cause cerebellar atrophy. This phenotype was associated with impaired autophagic clearance and subsequent caspase-induced cell death 26 . This work suggests that mutations in the VPS15-VPS34-BECLIN1 complex may be associated with neurological disorders, both common and rare. Indeed, there is some evidence to suggest a variant within the promoter of VPS34 may be associated with schizophrenia 37 . In summary, this work highlights the utility of forward-driven genetic screens to gain novel insights into the molecular basis of telencephalic development and underscores the importance of the Vps15-Vps34 complex in neuronal migration and survival.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-017-0053-5.
Articles
NaTure NeuroscieNce Methods ENU screen. C57BL/6 male mice (Mus musculus) were given ENU injections and subsequently crossed with C3H/HeH females to generate G1 founder males. These founders were then out-crossed to C3H/HeH and the G2 daughters backcrossed to the G1 Founder male. Adult G3 mice aged approximately 16 weeks were killed for analysis and their brains postfixed in 4% paraformaldehyde (PFA) before dehydration in 30% sucrose. Brains were sectioned coronally (40 μ m) and stereotaxically matched sections through the telencephalon (bregma -2.06 mm) were mounted on electrostatically charged slides and Nissl stained (0.6% cresyl violet). Sections were scanned using an Epson Perfection V750 Pro scanner and the following measurements recorded using the Image J software package: volume of the third ventricle and lateral ventricles; total brain volume; corpus callosum volume; thickness of the cortex; length of the pyramidal cell layer of the hippocampus; thickness of the molecular layer of the hippocampus; thickness of the stratum oriens of the hippocampus. For each genotype, at least 12 animals were analyzed.
Genetic mapping, exome sequencing and genotyping. DNA was extracted by standard techniques and 51 microsatellite markers covering all autosomes were amplified by PCR and visualized on agarose gels stained with ethidium bromide (4%). This established linkage to chromosome 9 between D9MIT11 and D9MIT81. Whole-exome sequencing was then performed using the Agilent whole-exome capture kit (SureSelectXT Mouse Kit, S0276129). Captured material was indexed and sequenced on the Illumina platform at the Wellcome Trust Sanger Institute. Exome sequence data were mapped to the mouse genome using Burrows-Wheeler Aligner (BWA) v0.5.9 and variants called using mPileUp within the SAMTools v0.1.19 suite 38 . The data has been submitted to the ENA (accession: ERS017958). The variant in Vps15 was confirmed by Sanger sequencing using the following primers: forward, AGTCCAACTGGCCTTAAACT; reverse, GTATAACCAAAATCCGCTCA, which were then employed to genotype animals for the subsequent studies. Mbe/Mbe animals were maintained on a C3H/He background. Vps15-conditional knockout animals were maintained on a C57/BL6 background. The Vps15 rescue line was created by injection of a modified BAC (RP24-281C16) into the pronuclei of B6CBAF1 zygotes. Transgenic founders were identified by PCR analysis (Supplementary Table 2 ) before crossing into the Mbe line. Animals were housed at the IMP/IMBA preclinical phenotyping facility with a maximum of six individuals per cage, with a 14-h light (6:00 to 20:00) and 10-h dark cycle. Cellular studies. Mouse embryonic fibroblasts (MEFs) were prepared from E13.5 embryos. The body (without head or liver) was minced and incubated in 0.05% trypsin-EDTA at 37 °C for 10 min and then triturated with a pipette tip. The suspension was centrifuged at 800 rpm for 5 min and the cell pellet suspended in culture medium (DMEM supplemented with 10% FBS (FBS), 2% l-glutamine (Sigma, G7513), 1% PenStrep (Sigma, P0781) and 1% nonessential amino acids (Sigma, M7145). The following day, cells were trypsinized in 0.15% trypsin EDTA, passed through a 70-μ m cell strainer and plated on gelatin-coated dishes. Human dermal fibroblasts were cultured in DMEM supplemented with 20% FBS, 1% l-glutamine, 1% PenStrep. For the EGFR degradation assay, cells were serumstarved in serum-free culture medium for 2 h. Culture medium was replaced with prewarmed uptake medium (DMEM supplemented with 2% l-glutamine, 1% PenStrep, 1% nonessential amino acids, 20 mM HEPES, 2% BSA and 100 ng/ mL mouse EGF-488 (Thermo Fisher Scientific, E-13345)), and cells were incubated for the indicated time periods. Cells were washed twice with ice-cold 1× PBS, then lysed in ice-cold lysis buffer. Autophagy flux was assessed as previously described 39 . Cells were treated with 200 nM (MEFs) or 400 nM (HDFs) of the lysosomal inhibitor Bafilomycin A1. Autophagy flux was calculated by assessing the accumulation of LC3-II, 2 h and 4 h following lysosomal inhibition. Specifically, flux was calculated by: (LC3-II 2 h/Gapdh)/(LC3-II 0 h/Gapdh) and (LC3-II 4 h/Gapdh)/(LC3-II 2 h/ Gapdh); n = 3 animals. The PDGF receptor degradation assay was performed as previously reported 16 (n = 3 animals per genotype, one or two technical replicates/ timepoint). Mouse embryonic fibroblasts (MEFs) were starved in medium containing 0.2% BSA for 24 h, then treated with 20 µ g/mL cycloheximide for 30 min before stimulation of receptor endocytosis by addition of 20 ng/mL PDGF-BB (Gibco, PMG0044) in starving medium supplemented with cycloheximide. At indicated timepoints, cells were washed twice with ice-cold 1× PBS and fixed in 4% PFA for 15 min, followed by permeabilization in 0.1% Triton X-100 in PBS. Cells were then incubated with primary antibody against PDGF receptor β (1:250, Cell Signaling #3169) followed by IRDye 800-labeled secondary antibody (LI-COR) and CellTag 700 stain (LI-COR) for normalization. Signal was detected using an Odyssey scanner (LI-COR). Signal from wells that were not treated with primary antibody was subtracted from the signal from sample wells, and empty wells were used for background subtraction. The half-life of PDGFR was calculated by fitting data to a one-phase decay curve using GraphPad Prism.
Rescue experiment in human cells. Human VPS15 cDNA was cloned into the pRRL lentiviral backbone downstream of a SFFV promoter 40 . For virus production, the transfer vectors psPAX2 (Addgene) and PMD2.G (Addgene) were transfected into Lenti-X (Clonetech) packaging cells. Human dermal fibroblasts were transduced with concentrated virus at an efficiency of > 90% as determined by mCherry expression. Four days after infection, cell lysates were prepared for western blot analysis.
Western blotting. Protein lysates were prepared in ice-cold RIPA buffer (10 mM TrisHCl pH 7.5, 150 mM NaCl, 1 mM EGTA, 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS) supplemented with protease and phosphatase inhibitor (Pierce #88668). Cells were incubated in lysis buffer for 15 min on ice before centrifugation. Frozen tissue samples were homogenized using a tungsten carbide bead in a Qiagen Tissue Lyser (2× 1 min, 20 Hz), incubated on ice for 1 h, then centrifuged twice for 20 min each time. Protein concentration was measured using a Pierce BCA Protein Assay Kit (#23225). Protein lysates were run on NuPAGE protein gels, blotted onto nitrocellulose or polyvinylidene fluoride membranes, blocked and probed with primary antibodies in 5% skimmed milk/TBST or 5% BSA/TBS. Antibodies targeting phosphoproteins were incubated with 1 mM sodium orthovanadate in 0.5% BSA/TBS. The following primary antibodies were used: 1:2,000 Vps15 for mouse studies (Novus Biologicals NBP1-30463) 39 , 1:1,000 VPS15 for human studies (Abcam ab124817, Abcam ab128903) 41 , 1:500 Vps34 (Cell Signaling, #3811) 42, 43 , 1:1,000 Beclin1 (Cell Signaling #3738) 44 , 1:500 p62 (Novus Biologicals, H00008878-M01) 45 , 1:2,000 GAPDH (Millipore, MAB374) 26, 46 , 1:1,000 ubiquitin (Santa Cruz, sc-8017) 47 , 1:10,000 α -tubulin (Sigma Aldrich, T6199) 48 , 1:100 LC3 (Nanotools, 0260-100/LC3-2G6) 49 , 1:600 EGFR (Cell Signaling #4267 S) 50 , 1:200 Nischarin (Santa Cruz, sc-365364) 21 , 1:500 PAK1 T423 (Cell Signaling, #2601 S) 51 and 1:500 N-terminal Vps15 antibody (Proteintech, 17894-1-AP). Western blots were quantified using ImageJ. Western blots were replicated at least once, yielding similar results.
qPCR. qPCR was performed as previously described 52 . This involved the dissection of brains from embryos (E10.5, E12.5, E14.5, E16.5 and E18.5) and postnatal mice (P0, P6 and adult). Samples were then frozen before mRNA extraction and cDNA synthesis (SuperScript III First-Strand Synthesis System, Invitrogen, 18080-051). We used SYBR green on a Bio-Rad Cycler together with intron spanning primers to amplify Vps15, Vps34, Beclin1 and Nischarin along with three control genes (Pgk1, Tfrc and Hprt; Supplementary Table 2) . Reactions were performed in triplicate and the Ct values ascertained. The geometric mean of the control genes was calculated, permitting determination of ∆ Ct and the relative mRNA level 53, 54 . For qPCR on human dermal fibroblast samples, qPCR used intron spanning primers to amplify VPS15, VPS34, BECLIN1 and three control genes (Supplementary Table 2 ).
Whole-brain proteomics. Quantitative tandem mass tags (TMT) proteomics was performed in accordance with previously described protocols 55 . First, flashfrozen hippocampi were homogenized in a buffer containing 8 M urea with 200 mM ammonium bicarbonate using a Qiagen tissue lyser at 20 Hz twice for 1 min each time. Samples were then treated with TCEB at 56 °C for 30 min and 7.5 µ L 5 mg/mL iodoacetamide solution for 30 min before dilution with 20 mM ABC and digestion with LysC (enzyme-to-protein ratio of 1:40 for 3 h at 37 °C). After this predigestion, samples were diluted with 200 mM ABC to a final urea concentration of 2 M. The tryptic digest was done with an enzyme-to-protein ratio of 1:40 for 2 h at 37 °C. Following desalting with C18 cartridges (Sep-Pak Vac 1 cc (50 mg)), samples were labeled with TMT in accordance with the manufacturer's specifications. TMT labeling reagents were equilibrated to room temperature and 41 µ L of anhydrous acetonitrile added before incubation with the samples for 1 h. Strong cation exchange chromatography (SCX) was performed using an Ultimate system (Thermo Fisher Scientific) at a flow rate of 25 µ L/min and a custom-made PolySULFOETHYL A (poly LC) column (5 µ m particles, 300 Å, 1 mm i.d. × 250 mm). A total of 300 µ g of peptide was loaded on the column, and 130 fractions were collected and stored at -80 °C. SCX fractions were then analyzed further using an UltiMate 3000 HPLC RSLCnano system (Thermo Scientific) coupled to a Q Exactive Plus mass spectrometer (Thermo Scientific) equipped with a Proxeon nanospray source. Fractions were loaded onto a trap column at a flow rate of 25 μ L/ min using 0.1% TFA as a mobile phase. After 10 min, the trap column was switched in line with the analytical column. Peptides were eluted using a flow rate of 230 nL/ min and a binary 180-min gradient. The two-step gradient started with the mobile phases: 95% A (water/formic acid, 99.9/0.1, v/v) and 5% B (water/acetonitrile/ formic acid, 19.92/80/0.08, v/v/v) increased to 10% B over the next 5 min and to 35% B over the next 55 min, followed by a gradient over 5 min to 90% B, where it was kept for 5 min, then decreased over 2 min back to the gradient 95% A and 5% B for equilibration at 30 °C. The Q Exactive Plus mass spectrometer was operated in data-dependent mode, using a full scan (m/z range 350-1,650, resolution of 70,000, target value 3 × 
Data exclusions
Describe any data exclusions.
Our initial experiments on human dermal fibroblasts were excluded as the cells tested positive for mycoplasm infection. These cells were treated with a Mycoplasm Removal Reagent containing a 4-oxoquinoline-3-carboxylic acid derivative. Following antibiotic treatment we confirmed on multiple occasions that our treated cells are mycoplasm negative (using a PCR based method). For our behavioural experiments animals and their corresponding littermates were excluded in instances where the software tracking failed.
Replication
Describe whether the experimental findings were reliably reproduced. This is indicated in the figure legends for each Figure. 
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Subjects were defined by the genotype -so randomization was not necessary.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
We employed strict blinding procedures. For all our behavioral experiments phenotyping was performed blind to genotype. For all histological analysis and cell counting imaged sections were blinded randomly, and then analysed before the condition/genotype was revealed. This is stated in the methods.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
We employed Graphpad PRISM (v7.0c) for our statistical analysis, and ImageJ (v1.51) for our image analysis . For the analysis of our mouse exome sequencing data we used Burrows-Wheeler Aligner (BWA) v0.5.9 and variants were called using mPileUp within the SAMTools v0. For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
There are no restrictions on the availability of materials.
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
For our ENU screen male C57BL/6 male mice (Mus musculus) were given ENU injections and subsequently crossed with C3H/HeH females to generate G1 founder males. These founders were then out-crossed to C3H/HeH and the G2 daughters backcrossed to the G1 Founder male. Adult G3 mice aged approximately 16 weeks were sacrificed and subject to phenotypic analysis. Following the identification of the Marble line it was maintained on a C3H/HeH background. Vps15 KO animals were maintained on a C57/BL6J background. For our behavioral experiments we employed n=20 animals with sex matched littermate pairs (n=9 females, n=11 males). Behavioral testing was performed on animals aged 12 weeks. Histological analysis of the Marble and Vps15 KO lines was performed on animals aged E14.5, P0, P11, 8 weeks and 4 months (n=3-6). Our histological analysis employing the Golgi method was performed on animals aged 4 months (n=3 animals per genotype). For our cellular experiments mouse embryonic fibroblasts (MEFs) were prepared from E13.5 embryos of all three genotypes (+/+, +/Mbe, Mbe/Mbe) (n=3). For our qPCR studies we employed tissue isolated from C57/BL6J animals aged E10.5, E12.5, E14.5, E16.5, E18.5 and postnatal mice P0, P6 and 8 weeks (n=3). For our in utero electroporation studies we used pregnant C57/BL6J females. Embryos were electroporated at E14.5, and then analyzed a E17.5 (n=3-6). The Vps15 rescue line was created by injection of a BAC (RP24-281C16) into the pronuclei of B6CBAF1 zygotes.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
We report all the relevant clinical details with respect to the patient with the L1224R mutation in Vps15 in the results of this manuscript. Specifically, the affected individual presented with severe cortical and optic nerve atrophy, localized cortical dysplasia, intellectual impairment, spasticity, ataxia, psychomotor delay, muscle wasting, pseudobulbar palsy, a mild hearing deficit and late onset epilepsy. He was homozygous for the L1224R mutation, whereas he parents were heterozygous.
